Efficacy of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in the Management of Left Ventricular Systolic Dysfunction According to Race, Gender and Diabetic Status: A Meta-Analysis of Major Clinical Trials
Women with asymptomatic LV systolic dysfunction may not achieve a mortality benefit when treated with ACE inhibitors.
Paul G. Shekelle, Michael W. Rich, Sally C. Morton, Sidney W. Atkinson, Wenli Tu, Margaret A. Maglione, Shannon Rhodes, Michael Barrett, Gregg C. Fonarow, Barry Grennberg, Paul Heidenreich, Tom Knabel, Marvin A. Konstam, Anthony Steimle, Lynne Warner Stevenson